What Are C15 Fatty Acid Supplements?
If you follow longevity or metabolic health news, you have likely encountered a growing conversation around C15 fatty acid supplements. These products contain pentadecanoic acid (C15:0), a saturated fatty acid with an unusual chemical structure that sets it apart from the more common palmitic acid or stearic acid found in most fats. Unlike the even-chain saturated fatty acids that dominate animal fats and tropical oils, C15:0 belongs to a class called odd-chain saturated fatty acids (OCSFA). Its primary natural source is dairy fat—whole milk, butter, cheese, and full-fat yogurt.
Until recently, odd-chain fatty acids received little attention. Researchers considered them minor dietary components with no particular biological significance. That perception has shifted dramatically. A growing body of research, much of it conducted by or funded by the company behind the leading C15 supplement brand Fatty15, suggests that pentadecanoic acid may play an important role in cellular health, metabolic regulation, and even longevity. The boldest claim—that C15:0 is the first essential fatty acid discovered in nine decades—has generated both excitement and skepticism. This guide synthesizes the available evidence, weighs the competing viewpoints, and provides practical guidance for anyone considering C15 supplementation in 2026.
The Science Behind C15:0: What Does Research Say?
Observational Studies: The Dairy Paradox
Interest in C15:0 began with epidemiological observations. Researchers noticed that people with higher circulating levels of pentadecanoic acid in their blood tended to have lower rates of type 2 diabetes, cardiovascular disease, and metabolic syndrome. Because C15:0 is a marker of dairy fat intake, these findings initially appeared to contradict the long-standing dietary guideline to limit saturated fat. The observation became known as the dairy paradox: dairy fat intake appeared neutral or even protective against cardiometabolic disease, despite its saturated fat content.
Numerous large cohort studies, including the Cardiovascular Health Study and the European Prospective Investigation into Cancer and Nutrition (EPIC), found inverse associations between circulating odd-chain fatty acids (C15:0 and C17:0) and incident type 2 diabetes. A 2021 meta-analysis of prospective studies confirmed that higher circulating C15:0 levels were associated with a lower risk of cardiovascular disease and type 2 diabetes. Importantly, these observational findings do not prove causation. People who consume more dairy fat may differ in other ways—diet quality, physical activity, socioeconomic status—that confound the association.
Randomized Controlled Trials: The Emerging Evidence
The first randomized controlled trial (RCT) specifically testing pure C15:0 supplementation was a small pilot study focused on non-alcoholic fatty liver disease (NAFLD). Published in 2023, the trial enrolled 12 adults with NAFLD and gave them 100 mg of pentadecanoic acid twice daily for 14 weeks. The results showed significant reductions in liver fat content as measured by MRI, along with improvements in liver enzymes (ALT and AST) and metabolic markers. While promising, the study lacked a placebo control group and had a very small sample size.
More recently, the TANGO pilot trial examined C15:0 supplementation in older adults. Preliminary results presented at scientific conferences suggest improvements in red blood cell membrane stability, metabolic flexibility, and inflammatory markers. A larger, placebo-controlled RCT is reportedly underway, and its results will be critical for evaluating the strength of the evidence. As of early 2026, no large-scale, independent, peer-reviewed RCTs of C15:0 supplementation have been published.
Mechanistic Research: How Might C15:0 Work?
Laboratory and animal studies have identified several plausible biological mechanisms that could explain the observed associations. Pentadecanoic acid appears to activate AMPK, a master regulator of cellular energy balance. AMPK activation improves glucose uptake, fatty acid oxidation, and mitochondrial function. C15:0 also activates PPARα and PPARδ, nuclear receptors that regulate lipid metabolism, inflammation, and cellular repair. These mechanisms overlap partially with those of omega-3 fatty acids, but with important differences in potency and downstream effects.
Another proposed mechanism involves red blood cell membrane stabilization. C15:0 integrates into cell membranes and may reduce fragility, a concept central to the Cellular Fragility Syndrome hypothesis discussed below. Laboratory studies show that C15:0 protects red blood cells from osmotic stress and mechanical damage, potentially improving oxygen delivery to tissues.
The Need for Independent Replication
A critical limitation of current C15:0 research is that much of it has been conducted or funded by Seraphina Therapeutics, the company that sells Fatty15. The CEO and co-founder of Seraphina, Dr. Stephanie Venn-Watson, is the lead author on many of the published studies. This conflict of interest does not invalidate the research, but it underscores the need for independent replication. The scientific community awaits studies from researchers with no financial stake in C15:0 supplementation. Until those studies appear, the evidence base remains provisional.
Is C15:0 an Essential Fatty Acid? The Controversy Explained
The most provocative claim surrounding C15:0 is that it qualifies as an essential fatty acid—the first new essential fatty acid discovered since the recognition of omega-3 and omega-6 fatty acids in the 1930s. Essential fatty acids cannot be synthesized by the human body in sufficient amounts and must be obtained from the diet. Deficiency leads to identifiable clinical symptoms that resolve when the nutrient is reintroduced.
The Case for Essentiality
Proponents of C15:0 essentiality, led by Seraphina Therapeutics, argue that C15:0 meets the criteria for an essential fatty acid. They point to evidence that C15:0 levels in human populations have declined as dairy fat consumption has fallen, and that this decline correlates with increased rates of metabolic disease. They have coined the term Cellular Fragility Syndrome (CFS) to describe a constellation of symptoms they attribute to C15:0 deficiency: weakened red blood cell membranes, increased inflammation, mitochondrial dysfunction, and metabolic inflexibility. According to this framework, many modern health problems stem, in part, from inadequate C15:0 intake.
Laboratory experiments show that cells grown in C15:0-depleted media exhibit fragility and metabolic impairment that can be reversed by adding C15:0 back. Animal models demonstrate similar findings. Proponents argue that these observations satisfy the classical definition of essentiality.
The Case Against Essentiality
Skeptics raise several objections. First, the National Academies of Sciences, Engineering, and Medicine—the body that establishes Dietary Reference Intakes—has not recognized C15:0 as an essential nutrient. No national or international health organization has done so. Second, the concept of Cellular Fragility Syndrome was developed by the company selling the supplement, which creates an inherent conflict of interest. Independent researchers have not validated CFS as a recognized medical condition.
Third, the decline in C15:0 levels does not, by itself, prove deficiency or disease causation. It may simply reflect changing dietary patterns. Fourth, the human body can synthesize small amounts of odd-chain fatty acids through bacterial fermentation in the gut and through alpha-oxidation of even-chain fatty acids. While endogenous production may not meet optimal levels, it may be sufficient to prevent classic deficiency symptoms. Finally, no large-scale population studies have demonstrated that C15:0 supplementation reverses disease or improves health outcomes in a manner that would be expected of an essential nutrient.
A Balanced Perspective
Reasonable scientists can disagree about whether C15:0 meets the formal definition of an essential fatty acid. What is clear is that C15:0 is a bioactive lipid with demonstrable effects on cellular and metabolic function. The essentiality debate may ultimately be less important than the practical question: Does C15:0 supplementation improve health outcomes? That question remains unanswered by high-quality evidence. Consumers should be aware that the essential fatty acid claim is a marketing position, not a settled scientific consensus. The patent held by Seraphina Therapeutics on the use of C15:0 for treating Cellular Fragility Syndrome adds a commercial dimension to the debate.
C15:0 vs. Omega-3: What's the Difference?
A common question is whether C15:0 is simply another form of omega-3. The answer is no. They are structurally and functionally distinct.
| Feature | C15:0 (Pentadecanoic Acid) | Omega-3 (EPA/DHA) |
|---|---|---|
| Chemical class | Saturated odd-chain fatty acid | Polyunsaturated fatty acid |
| Carbon chain length | 15 carbons | 20–22 carbons |
| Double bonds | None | Multiple (5–6) |
| Oxidative stability | Very high (resistant to rancidity) | Low (prone to oxidation) |
| Primary dietary sources | Whole-fat dairy, some fish | Fatty fish, algae, fish oil |
| Key biological targets | AMPK, PPARα, PPARδ | PPARα, COX enzymes, resolvins |
| Membrane effects | Stabilizes membranes | Increases membrane fluidity |
| Common supplement form | Capsule (free fatty acid) | Capsule (triglyceride or ethyl ester) |
Because C15:0 is a saturated fat, it is highly resistant to lipid peroxidation, the oxidative damage that can affect polyunsaturated fats like omega-3s. Some researchers suggest that C15:0 may complement omega-3s by providing membrane stabilization and AMPK activation, while omega-3s contribute anti-inflammatory signaling through specialized pro-resolving mediators. The two are not interchangeable, and proponents recommend taking both, not one in place of the other.
Food Sources of C15:0: Can You Get Enough from Diet?
Pentadecanoic acid is found almost exclusively in animal fats, with dairy fat being the richest dietary source. Plant foods contain negligible amounts. The table below summarizes common dietary sources and their approximate C15:0 content.
| Food (100 g serving) | Approximate C15:0 Content (mg) | Notes |
|---|---|---|
| Whole milk (3.25% fat) | 20–40 | Varies by cow diet and season |
| Butter (salted) | 200–400 | Concentrated dairy fat |
| Cheddar cheese | 150–250 | Full-fat varieties only |
| Full-fat Greek yogurt | 30–60 | Fat content determines amount |
| Heavy cream | 150–300 | High fat density |
| Salmon (wild) | 5–15 | Trace amounts only |
| Beef (grain-fed) | 10–20 | Much less than dairy |
| Lamb | 10–25 | Slightly higher than beef |
The typical Western diet provides approximately 50–150 mg of C15:0 per day, depending on dairy intake. For comparison, the dose used in clinical trials and recommended by supplement manufacturers is 100–300 mg per day. Achieving 300 mg from diet alone would require consuming roughly 75–150 grams of butter or 1.2–2.4 liters of whole milk daily. For most people, that level of dairy consumption is impractical and would come with significant amounts of saturated fat, calories, and potential digestive discomfort.
This is where C15 fatty acid supplements offer a practical advantage. A single 100 mg capsule provides a concentrated dose of pure pentadecanoic acid without the accompanying calories, lactose, or pro-inflammatory fats. For individuals who do not consume dairy, are lactose intolerant, or follow a vegan diet (though C15:0 is animal-derived), supplementation may be the only way to achieve meaningful intake. However, it bears repeating that the optimal intake of C15:0 has not been established, and the concept of deficiency remains contested.
Popular C15 Supplement Brands: A Comparison
The C15 supplement market remains small, with Fatty15 dominating the category. A few generic pentadecanoic acid products have appeared on Amazon, but quality and transparency vary. The table below compares the most widely available options as of early 2026.
| Brand | Product Form | Dose per Serving | Servings per Container | Price per Serving | Third-Party Tested | Key Ingredients |
|---|---|---|---|---|---|---|
| Fatty15 | Original capsule | 100 mg C15:0 | 90 | $0.67 | Yes (NSF, Informed Choice) | Pure C15:0 free fatty acid, rice flour capsule |
| Fatty15 | Gummy | 100 mg C15:0 | 60 | $0.83 | Yes (NSF) | C15:0, pectin, sugar, natural flavors |
| Fatty15 | Advanced capsule | 300 mg C15:0 + 200 mg C17:0 | 60 | $1.33 | Yes (NSF) | C15:0, C17:0 (heptadecanoic acid) |
| Generic Pentadecanoic Acid (Amazon) | Capsule | 100 mg | 60–120 | $0.40–$0.60 | Varies (not always disclosed) | C15:0, rice flour, gelatin capsule |
| Bulk Supplements Pentadecanoic Acid | Powder | 100–500 mg (user measured) | 100–200 g | $0.20–$0.50 | No (lab-tested but no seal) | Pure C15:0 powder |
Fatty15 Review
Fatty15 is the most established and best-documented C15 supplement brand. It is the product line of Seraphina Therapeutics and has undergone third-party testing for purity and potency. The company provides a Certificate of Analysis for each batch. Customer reviews are generally positive, with users reporting improved energy, better sleep, and reduced joint discomfort. Negative reviews cite the high cost per serving and the fact that results can take months to notice. The gummy version contains added sugar, which some health-conscious users may want to avoid. The Advanced version adds C17:0 (heptadecanoic acid), another odd-chain saturated fatty acid with some independent research backing, but the evidence for C17:0 is even more limited than for C15:0.
Generic and Amazon Brands
Generic pentadecanoic acid capsules sold on Amazon are considerably cheaper but lack the quality assurance and batch-level testing that Fatty15 offers. Some products do not specify the source or purity of their C15:0, and third-party certification is inconsistent. For a supplement that is relatively new and expensive, choosing a reputable brand with transparent testing is advisable. Bulk powder offers the lowest cost per milligram but requires careful measuring and may have an unpleasant taste and texture.
Potential Benefits of C15 Supplementation: What the Evidence Shows
It is important to distinguish between claims that are supported by human clinical trials, those supported only by animal or laboratory studies, and those that are hypothetical. The table below summarizes the evidence level for each claimed benefit.
| Claimed Benefit | Level of Evidence | Key Source | Caveats |
|---|---|---|---|
| Reduced liver fat in NAFLD | Pilot human trial (uncontrolled) | Woo et al., 2023 | No placebo group, very small sample |
| Improved red blood cell membrane stability | Laboratory and animal studies; preliminary human data | Venn-Watson et al., 2020 | Company-funded; needs independent replication |
| AMPK activation and improved metabolic flexibility | Laboratory and animal studies | Venn-Watson et al., 2021 | In vitro data only; human translation uncertain |
| Reduced inflammation (lower IL-6, TNF-α) | Animal studies; mixed human data | Venn-Watson et al., 2022 | Company-funded; effect size modest |
| Improved cognitive function | Animal studies only | Unpublished (per company reports) | No human trials available |
| Enhanced immune function | Laboratory studies only | Venn-Watson et al., 2022 | Preliminary; mechanism plausible but unproven in humans |
| Longevity and anti-aging | Hypothetical (based on AMPK/PPARα activation) | None | No direct evidence in humans |
| Reduced risk of chronic disease (diabetes, CVD) | Observational studies only | Various cohort studies | Association does not prove causation |
What the Evidence Does and Does Not Support
The strongest evidence supports C15:0's ability to improve red blood cell membrane stability and reduce liver fat in NAFLD. Both findings come from pilot studies that require confirmation in larger, placebo-controlled trials. The AMPK and PPAR activation mechanisms are biologically plausible and consistent with known pharmacology, but they have not been robustly demonstrated in humans at the doses used in supplements. Claims about cognitive enhancement, longevity, and chronic disease prevention are speculative at this stage.
Consumers should approach benefit claims with the understanding that the C15:0 research base is still forming. The most rigorous studies have been conducted by a single company with a commercial interest in positive results. That does not make the findings wrong, but it means they need independent confirmation. For a supplement that costs $20–$40 per month, the evidence is promising but not conclusive.
Side Effects, Safety, and Dosage Recommendations
Safety Profile
C15:0 has received Generally Recognized as Safe (GRAS) status from the U.S. Food and Drug Administration for use in foods and supplements. This designation means that FDA experts have determined the ingredient is safe under its intended conditions of use. GRAS status is based on existing scientific data and does not require pre-market approval. C15:0 has been consumed in dairy fat for millennia, which provides a long history of safe human exposure at dietary levels.
The safety of C15:0 supplementation at doses of 100–300 mg per day appears acceptable based on available data. The NAFLD pilot trial reported no serious adverse events. Mild digestive side effects, including gas, bloating, and loose stools, occurred in some participants, particularly at higher doses. No studies have evaluated long-term safety beyond 14–16 weeks. The use of C15:0 in pregnant or breastfeeding women, children, or individuals with pre-existing medical conditions has not been studied.
Dosage Recommendations
No official recommended daily intake for C15:0 exists. The commonly recommended doses are based on what has been used in clinical trials and what is sold by supplement companies. The standard dose is 100 mg taken twice daily (200 mg total) or a single 300 mg dose for the Advanced version. Starting with a lower dose (100 mg once daily) and gradually increasing may help minimize digestive side effects. Taking C15:0 with food may improve absorption and reduce gastrointestinal discomfort.
Potential Drug Interactions
Theoretically, C15:0 could interact with medications that affect lipid metabolism, including statins, fibrates, and anticoagulants. By activating PPARα, C15:0 may influence lipid levels in ways that could add to or interfere with these medications. No clinical studies have examined these interactions. Anyone taking prescription medications should consult a healthcare provider before starting C15:0 supplementation.
Who Should Consider Taking C15 Supplements?
C15:0 supplementation is not necessary or appropriate for everyone. The following groups may be most likely to benefit, while others may derive little advantage.
People with Low or No Dairy Intake
Individuals who avoid dairy due to lactose intolerance, veganism, allergies, or personal preference typically have very low C15:0 intake. If C15:0 proves to be beneficial for health, this group is most likely to benefit from supplementation. Plant-based diets are virtually devoid of odd-chain saturated fatty acids.
Individuals Focused on Cellular Health and Metabolic Support
Those interested in optimizing metabolic function, supporting mitochondrial health, and maintaining cellular membrane integrity may find C15:0 supplementation appealing, particularly if they already take omega-3s and are looking for complementary support. The anti-aging and longevity angle is popular, though unproven.
People with Metabolic Syndrome or NAFLD
Early evidence, while limited, points to potential benefits for liver fat reduction and metabolic markers. Individuals with metabolic syndrome, pre-diabetes, or non-alcoholic fatty liver disease might consider discussing C15:0 with their healthcare provider. It is not a substitute for lifestyle interventions like diet, exercise, and weight management.
Older Adults
Aging is associated with increased cellular fragility, mitochondrial dysfunction, and metabolic decline. The TANGO pilot trial specifically targeted older adults. While the results are preliminary, older individuals may be a key demographic for C15:0 supplementation if larger trials confirm the findings.
Who May Not Need C15:0
People who consume whole-fat dairy products regularly—several servings per day of milk, yogurt, cheese, or butter—likely obtain meaningful amounts of C15:0 from their diet. Supplementing on top of a dairy-rich diet may provide diminishing returns. Similarly, individuals with normal metabolic health, no signs of cellular fragility, and no interest in longevity optimization may not see noticeable benefits. The supplement is relatively expensive, and the evidence does not support universal recommendation.
Key Takeaways
- C15:0 (pentadecanoic acid) is an odd-chain saturated fatty acid found primarily in dairy fat, distinct from both even-chain saturated fats and polyunsaturated omega-3s.
- Observational studies link higher blood levels of C15:0 to lower risks of type 2 diabetes and cardiovascular disease, but these associations are not causal.
- Early human trials show promise for liver fat reduction in NAFLD and improved red blood cell membrane stability, but both studies are small, uncontrolled, and company-funded.
- The claim that C15:0 is an essential fatty acid is controversial; it has not been recognized by the National Academies or any major health organization.
- Dietary intake of C15:0 has declined as dairy fat consumption has fallen, and achieving therapeutic doses from food alone is difficult for most people.
- Fatty15 is the dominant brand with third-party certification, but generic options exist at lower cost with less quality assurance.
- Doses of 100–300 mg per day appear safe based on short-term data; mild digestive side effects are possible when starting.
- The evidence base is promising but incomplete; independent research is urgently needed to confirm or refute the current findings.
- C15:0 is not a replacement for omega-3s, vitamin D, or other established supplements; it may play a complementary role.
- Consult a healthcare provider before starting C15:0, especially if taking medications or managing a chronic condition.
FAQs About C15 Fatty Acid Supplements
What is the best source of C15?
The best dietary sources are whole-fat dairy products like milk, butter, and cheese. For those who want a clean, concentrated source without added pro-inflammatory fats, a C15 supplement such as pentadecanoic acid capsules is a practical option. Fatty15 is the most well-documented brand.
Does Greek yogurt have C15 in it?
Yes, Greek yogurt made from whole milk contains pentadecanoic acid naturally, as it is a dairy product. The amount depends on the fat content; full-fat Greek yogurt contains more than low-fat or non-fat varieties. A typical serving of full-fat Greek yogurt provides about 15–30 mg of C15:0.
What is C15 supplement good for?
Proponents claim C15 supplements support metabolic health, cognitive function, immune response, liver health, and red blood cell stability. Early research, largely from the company that markets Fatty15, shows promise, but independent human trials remain limited. The strongest evidence supports benefits for red blood cell membrane stability and liver fat reduction.
Is C15 the same as omega-3?
No. C15:0 is a saturated odd-chain fatty acid, while omega-3s are polyunsaturated. They have different structures, functions, and dietary sources. C15 is more stable against oxidation and is often marketed as a complement to omega-3s, not a replacement. Both activate some shared pathways (like PPARα), but through different mechanisms.
Are there any negative reviews of Fatty15?
Yes. Independent reviews from organizations like CSPI and podcasts like The Proof have criticized the marketing claims, the lack of independent studies, the high cost, and the conflict of interest from a company funding its own research. Some users report not noticing any difference after months of use. The evidence does not yet support calling C15 an established essential fatty acid or a proven longevity supplement.
Where can I buy C15 supplements?
C15 supplements like Fatty15 are available directly from the manufacturer's website and through Amazon. Generic pentadecanoic acid capsules and bulk powder are also sold on Amazon and at some health food stores. Third-party tested products offer greater assurance of purity and potency.
How much C15:0 should I take daily?
Most studies have used 200 mg per day (100 mg twice daily) or 300 mg once daily as a higher dose. No official recommendation exists, so starting with 100 mg daily and gradually increasing based on tolerance and response is reasonable. Taking C15:0 with food may improve absorption and reduce digestive side effects.
Can I get enough C15:0 from butter alone?
Butter is one of the richest dietary sources of C15:0, but reaching 200 mg daily would require eating about 50–100 grams of butter (3.5–7 tablespoons), which delivers roughly 400–800 calories and 45–90 grams of total fat. For most people, this is neither practical nor advisable. Supplementation offers a more efficient way to obtain concentrated C15:0.
Is C15:0 safe for long-term use?
Short-term studies lasting up to 16 weeks have found C15:0 to be safe and well tolerated at doses up to 300 mg per day. Long-term safety data beyond a few months are not available. The long history of dairy consumption suggests that C15:0 is safe at dietary levels, but high-dose chronic supplementation has not been studied for extended periods.
Does C15:0 interact with statins or blood thinners?
No clinical interaction studies have been conducted. Because C15:0 activates PPARα, a target of fibrate drugs, it could theoretically affect lipid metabolism in ways that interact with statins or other lipid-lowering medications. Anyone taking prescription medications should consult their healthcare provider before starting C15:0 supplementation.
What does Cellular Fragility Syndrome mean?
Cellular Fragility Syndrome (CFS) is a term coined by Seraphina Therapeutics to describe a hypothesized condition caused by C15:0 deficiency. Symptoms include weakened red blood cell membranes, increased inflammation, mitochondrial dysfunction, and metabolic inflexibility. CFS is not recognized by major medical organizations and has not been validated by independent research. It remains a controversial concept tied to a commercial interest.
Can vegans take C15 supplements?
All known sources of C15:0 are animal-derived, primarily from dairy fat. There are no plant-based sources of pentadecanoic acid. Vegans who wish to take C15:0 would need to use an animal-derived supplement, which may conflict with their dietary philosophy. No synthetic or fermentation-derived C15:0 is currently available, though that could change in the future.
Bottom Line: Should You Take a C15 Supplement?
C15:0 is one of the most interesting and controversial emerging supplements in the metabolic health space. The science is real, biologically plausible, and supported by early human data. At the same time, the evidence base is immature, heavily influenced by the company that profits from supplement sales, and missing the independent replication that would transform promise into proof.
For someone with low dairy intake, metabolic concerns like NAFLD, or an interest in cutting-edge cellular health optimization, a C15 fatty acid supplement is worth considering—with eyes open. It is not a miracle molecule, not a proven essential nutrient, and not a substitute for foundational health habits. It is a bioactive lipid that may offer real benefits, particularly for red blood cell health and metabolic function, while coming with a relatively favorable safety profile based on short-term data.
For someone who consumes dairy regularly, expects dramatic results, or is looking for a scientifically settled supplement with decades of clinical backing, C15:0 may disappoint. The cost is significant, the evidence is evolving, and some of the marketing claims outpace the data.
A reasonable approach is to discuss C15:0 with a healthcare provider, particularly if you have a medical condition or take medications. If you decide to try it, choose a reputable brand with third-party testing, start with a low dose, track your experience over several months, and be honest about whether you notice meaningful changes. The story of C15:0 is still being written, and the most important research—large, independent, long-term human trials—has yet to be published. For now, informed curiosity is the healthiest stance.
For those looking to build a comprehensive supplement routine, C15:0 may fit alongside other foundational nutrients. You can explore related topics such as vitamin C for immune and antioxidant support, vitamin D for bone and immune health, and magnesium for energy and muscle function to build a balanced approach to wellness.
pentadecanoic acid, C15 fatty acid supplements, C15 benefits, fatty15 review, best C15 supplement, C15 deficiency, cellular fragility syndrome, odd-chain saturated fatty acids, pentadecanoic acid side effects, C15 dosage, C15 safety, C15 vs omega-3, C15 food sources, C15 clinical trials, pentadecanoic acid capsules, C15 supplement brands, C15 for NAFLD, C15 cellular health, essential fatty acid controversy, Seraphina Therapeutics
